Take a look at this Bioject chart -
Look at what occurs when there is good news - it really goes strongly. And it seems to me that the best news is ahead, not behind.
This stock has a small float, and if Bioject is brought into this as a partner, even $200 per share would not surprise me. Look what happened a few years back when it took off on far less explosive news.
If that is true, this is a $100 stock, at minimum. I see in the Wall Street Journal today that the World Health Organization is predicting that 2 billion people could potentially get the Swine Flu.
I don't know if I can overstate how important this is, and how likely it is that it will be a Bioject device being used when the FDA approval comes... which it will.
We're above breakeven right now minus one time charges... 2 dollars by the end of the year is possible now, imo.